| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068703 Modulating the interaction of immune complexes with tissue Fc receptors by introducing an inhibitor of an endogenous kinase |
| 06/06/2002 | US20020068698 13237, 18480, 2245 or 16228 novel human protein kinase molecules and uses therefor |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068694 Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B |
| 06/06/2002 | US20020068363 Enhancing cell competence by recursive sequence recombination |
| 06/06/2002 | US20020068362 Increased transgene expression in retroviral vectors having a scaffold attachment region |
| 06/06/2002 | US20020068359 Nucleotide sequences coding regulatory sequences; for use in generating genetically engineered plant |
| 06/06/2002 | US20020068354 Genetically engineering hematopoietic progenitor cells; obtain cells, transform with vector, monitor cells for expression of vector proteins |
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068350 Enzymatic polypeptide for use in nutrients of animal feeds |
| 06/06/2002 | US20020068349 Nucleotide sequences coding enzymatic polypeptide for use in the generation of trehalose |
| 06/06/2002 | US20020068348 42755, a novel human methyltransferase family member and uses thereof |
| 06/06/2002 | US20020068347 Membrane protein for use in the diagnosis and prevention of cancer |
| 06/06/2002 | US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases |
| 06/06/2002 | US20020068344 MDR-like ABC transporter gene from plants |
| 06/06/2002 | US20020068343 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068340 Combinatorial enzyme development |
| 06/06/2002 | US20020068337 Method for enhancing activity to regenerate electron acceptor for oxidoreductase in microorganism capable of producing said oxidoreductase, and use of microorganism prepared by said method |
| 06/06/2002 | US20020068335 Processes for preparing D-pantothenic acid using coryneform bacteria |
| 06/06/2002 | US20020068333 Generating preferential nucleotide sequences; obtain nucleic acids, clone into vector, detect and recover overlapping clones, sequence clones |
| 06/06/2002 | US20020068332 Generating expression vector coding polyketide synthases; generate nucleotide sequences, obtain cells, transform cells, recover polytketide synthases |
| 06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
| 06/06/2002 | US20020068325 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 06/06/2002 | US20020068324 Transgenic mice containing melanocortin-3 receptor gene disruptions |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068322 47765, a novel human lysyl oxidase and uses thereof |
| 06/06/2002 | US20020068321 Splice choice antagonists as therapeutic agents |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068318 Production of human mutated proteins in human cells by means of homologous recombination |
| 06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
| 06/06/2002 | US20020068294 Probe for detecting a highly ordered structural site of a single stranded nucleic acid of a gene, and a method and a device for detecting the same |
| 06/06/2002 | US20020068292 Extracting nucleotide sequences from waste; obtain waste, incubate with hexadecyltrimethylammonium bromide, extract nucleotide sequences |
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068288 Nucleotide sequences for use as anticarcinogenic agents in the treatment of tumors in lungs |
| 06/06/2002 | US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068284 Genetically engineering preferential bacteria; obtain bacteria, transform with expression vector, monitor bacteria for intensified mutation activity |
| 06/06/2002 | US20020068280 Isolating nucleotide sequences; obtain blood, lyse, remove leukocytes, lyse, extract nucleotide sequences, precipitate proteins, resuspend nucleotide sequences in solution |
| 06/06/2002 | US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent |
| 06/06/2002 | US20020068277 Evaluating open reading frames of preferential eukaryotic and prokaryotic organisms; obtain ribonucleic acid sequences, generate single sranded nucleotide sequences, amplify, deterimine seqence |
| 06/06/2002 | US20020068276 Methods for selecting functional polypeptides |
| 06/06/2002 | US20020068272 Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors |
| 06/06/2002 | US20020068070 High molecular weight major outer membrane protein of moraxella |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068068 Pathogenic bacteria (e.g. Haemophilus, E. Coli, Salmonella) having non-reverting genetic mutations which alter activity of DNA adenine methylase (Dam); vaccines |
| 06/06/2002 | US20020068067 Recombination m. tuberculosis mycobacterium auxotrophic for leucine and vaccines using same |
| 06/06/2002 | US20020068066 Method for the treatment and prevention of dental caries |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions |
| 06/06/2002 | US20020068059 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 06/06/2002 | US20020068052 Replication defective; use treating retinitis pigmentosa |
| 06/06/2002 | US20020068050 Made by transfecting with an expression vector of a nucleotide sequence encoding an active agent such as cytokines or peptide hormones; use in transplantation to prevent tissue rejection, wound healing |
| 06/06/2002 | US20020068049 Tissue specific adenoviral vectors |
| 06/06/2002 | US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 06/06/2002 | US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers |
| 06/06/2002 | US20020068043 Fusion protein, comprising a receptor-antagonizing domain (such as prolactin receptor antagonist) and a positive immunomodulator domain (such as an interleukin); combines apoptosis induction and immunotherapy |
| 06/06/2002 | US20020066866 Image reading method and apparatus |
| 06/06/2002 | US20020066812 Process and device for the extraction of DNA, RNA and proteins from biological samples |
| 06/06/2002 | US20020066144 Redeposition or backstain inhibition during stonewashing process |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10130849A1 Transfection using complex of plasmid, peptide and lipid, are useful in medicine, where the peptide comprises oligolysine sequence |
| 06/06/2002 | DE10060140A1 Multimerer mehrfach-antigenbindender einzelkettiger Antikörper Multimeric multiple antigen-binding single chain antibody |
| 06/06/2002 | DE10059630A1 Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor Medicines used to prevent or treat by human papillomavirus type 18-evoked tumor |
| 06/06/2002 | DE10058091A1 Isolierte Luziferasen Lu164, LuAL und Lu22, sowie deren Verwendung Isolated luciferases Lu164, LuAL and Lu22, and their use |
| 06/06/2002 | DE10057853A1 Identifying agents that inhibit the function of specific RNA, useful e.g. for treating human or feline immune deficiency virus, comprises using a target-reporter construct prepared from a reporter ribozyme domain |
| 06/06/2002 | DE10057841A1 Verfahren zum Nachweis von Protozoen der Gattung Naegleria A method for the detection of protozoa of the genus Naegleria |
| 06/06/2002 | DE10055789A1 DNA-Sequenz und Microcin aus Escherichia coli StammDSM 6601 DNA sequence and Microcin from Escherichia coli 6601 StammDSM |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2604066A1 Compositions and methods for diagnosing or treating psoriasis |
| 06/06/2002 | CA2449412A1 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2436910A1 Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates |
| 06/06/2002 | CA2436903A1 Immunotherapeutic methods and molecules |
| 06/06/2002 | CA2436778A1 Floral development genes |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430745A1 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | CA2430625A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | CA2430503A1 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 06/06/2002 | CA2430495A1 Oncolytic virus |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430473A1 Diagnosis and treatment of disease |
| 06/06/2002 | CA2430378A1 Substrate linked directed evolution (slide) |
| 06/06/2002 | CA2430373A1 Nucleic acid amplification methods |
| 06/06/2002 | CA2430365A1 Neurotoxins with enhanced target specificity |
| 06/06/2002 | CA2430351A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | CA2430331A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | CA2430269A1 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430138A1 Compositions and methods for extracting a nucleic acid |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2430084A1 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |